EARLY ACHIEVEMENT OF PARTIAL MAYO SCORE REMISSION AND IBDQ NORMALIZATION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FILGOTINIB IN THE PHASE 2B/3 SELECTION STUDY

Marc Ferrante  ¹     Alessandra Oortwijn  ²     Brian G. Feagan  ³     Chohee Yun  ⁴     Jie Zhang  ⁴     Laurent Peyrin-Biroulet  ⁵     Severine Vermeire  ⁵     Silvio Danese  ^6    
1 Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium
² Galapagos NV, Leiden, Netherlands
³ Robarts Research Institute, Western University, London, ON, Canada
⁴ Gilead Sciences Inc., Foster City, CA, United States
⁵ Inflammatory Bowel Disease Unit, Nancy University Hospital, Nancy, France
⁶ IBD Center, Humanitas Research Hospital, Milan, Italy

Topic
IBD

Session
IBD: Clinical trials II (small molecules)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)